Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,666 INR | +0.25% | +3.48% | +25.91% |
May. 13 | Lupin Relaunches Mirabegron ER Tablets in US | MT |
May. 09 | Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.91% | 9.07B | |
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- Lupin Launches Fertility Medicine Ganirelix in US